Back to companies
Keros Therapeutics, Inc.
KROSUSNASDAQPharmaceuticals & HealthcareKeros Therapeutics, Inc.
Revenue
$244.1mn
YoY +6775.0%
Operating income
$67.6mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API